Kore Private Wealth’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2K | Hold |
559
| – | – | ﹤0.01% | 261 |
|
|
2022
Q2 | $3K | Hold |
559
| – | – | ﹤0.01% | 308 |
|
|
2022
Q1 | $6K | Hold |
559
| – | – | ﹤0.01% | 319 |
|
|
2021
Q4 | $6K | Hold |
559
| – | – | ﹤0.01% | 305 |
|
|
2021
Q3 | $11K | Hold |
559
| – | – | ﹤0.01% | 448 |
|
|
2021
Q2 | $14K | Hold |
559
| – | – | ﹤0.01% | 425 |
|
|
2021
Q1 | $16K | Hold |
559
| – | – | ﹤0.01% | 369 |
|
|
2020
Q4 | $12K | Hold |
559
| – | – | ﹤0.01% | 335 |
|
|
2020
Q3 | $14K | Hold |
559
| – | – | ﹤0.01% | 273 |
|
|
2020
Q2 | $13K | Hold |
559
| – | – | ﹤0.01% | 741 |
|
|
2020
Q1 | $4K | Hold |
559
| – | – | ﹤0.01% | 858 |
|
|
2019
Q4 | $6K | Hold |
559
| – | – | ﹤0.01% | 844 |
|
|
2019
Q3 | $5K | Hold |
559
| – | – | ﹤0.01% | 228 |
|
|
2019
Q2 | $8K | Hold |
559
| – | – | ﹤0.01% | 228 |
|
|
2019
Q1 | $22K | Hold |
559
| – | – | 0.01% | 501 |
|
|
2018
Q4 | $9K | Buy |
+559
| New | +$9K | ﹤0.01% | 586 |
|